3620 results for «469»
3620 results
HighLife TSMVR and their latest experiences, moving forward
29 Nov 2022 – From PCR London Valves 2022
A panel of experts review the latest clinical data, study progress and future plans regarding mitral valve replacement, and the position of HighLife, a new technology in this field.
Create the future of TAVI - Optimisation of the procedure and patient pathway
27 Nov 2022 – From PCR London Valves 2022
Dive into this session to discover what can be improved today to be ready to treat future TAVI patient volumes. You'll also learn how to set up a successful TAVI coordinating team and adopt it in your hospital, and how to create a win-win partnership with...
Remaining unmet needs and strategies in TAVI
28 Nov 2022 – From PCR London Valves 2022
Watch this session to understand why valve design impacts future patient outcomes and how hemodynamics can impact decision-making and the durability of the TAVI devices. At the end of the session, you'll also get an overview of Medtronic's portfolio.
Technical challenges and optimal device choice for complex TAVI procedures
28 Nov 2022 – From PCR London Valves 2022
This session reflects on the importance of device choice and implantation technique in complex TAVI procedures. Learn how to anticipate the risks of a valve-in-valve procedure in small surgical prostheses, and discover the latest technological evolutions for treating patients with complex anatomy.
Innovations in TMVR and Intrepid trial updates
29 Nov 2022 – From PCR London Valves 2022
Watch this session if you want to gain insights on the APOLLO TMVR trial, the Intrepid trial and to hear about future innovations in mitral replacement.
The VitaFlow TAVI system - A new device that delivers exceptional patient outcomes
29 Nov 2022 – From PCR London Valves 2022
In this session, a panel of experts introduce the VitaFlow TAVI system, a good option for patients with complex anatomies. They also present the five-year results of VitaFlow in severe aortic stenosis.
Primary mitral regurgitation: treatment options when the anatomy is simple
27 Nov 2022 – From PCR London Valves 2022
Consult this session to learn about the different technical aspects and limitations for both surgical and catheter-based techniques and to understand the design and implications of two current RCTs comparing interventional and surgical techniques in patients with primary mitral regurgitation.
TAVI innovations
27 Nov 2022 – From PCR London Valves 2022
Discover some of the latest innovations in TAVI presented at PCR LV 2022: zero-contrast TAVI, emerging technique for coronary protection in ViV TAVR, first dedicated splitting device in a degenerated TAVR at risk for double coronary obstruction, and much more!
Primary mitral regurgitation: key imaging requirements for diagnosis and procedural planning
27 Nov 2022 – From PCR London Valves 2022
In this session, find out more about the most common types of primary mitral regurgitation and methods for their evaluation, the principal indications for intervention, as well as the available modes of therapy (surgical/transcatheter) and most appropriate choices for individual patients.
Tricuspid interventions
27 Nov 2022 – From PCR London Valves 2022
How to manage tricuspid valve disease in a patient with atrial fibrillation, transcatheter tricuspid valve repair with transthoracic echocardiography guidance, or a patient with severe tricuspid regurgitation with a novel transcatheter treatment? Watch this PCR LV 2022 session for answers!
Repair vs. replacement for the treatment of tricuspid valve disease
27 Nov 2022 – From PCR London Valves 2022
Watch this session on tricuspid valve disease to learn more about its current modes of treatment (including new and emerging devices), to understand which patients are the best candidates for this procedure and to explore the challenges that may be encountered during it.
Valve-in-valve TAVI: session 1
27 Nov 2022 – From PCR London Valves 2022
ViV TAVI in a patient with previous Bentall's operation, ViV for a failed surgical aortic bioprosthesis with a misaligned mitral bioprosthesis, TAVI for severe aortic regurgitation caused by infective endocarditis after homograft surgery, and much more in this PCR LV 2022 session about ViV TAVI!
TAVI: emerging evidence
27 Nov 2022 – From PCR London Valves 2022
Through the 5 abstracts of this PCR LV 2022 session, follow the comparison between last-generation balloon and self-expandable TAVR for bicuspid aortic valve stenosis, and the comparison between multiple tools to assess the risk of mortality after TAVR, evaluate the impact of post-TAVI vascular complications, and...
TAVI complications: Session 1
27 Nov 2022 – From PCR London Valves 2022
Consult this session to discover a selection of challenging TAVI complications cases: an annular rupture after TAVI in a bicuspid aortic valve, an outflow tract rupture during self-expandable transcatheter valve implantation, a periprocedural TAVI ischaemic stroke, and more!
TAVI challenges: session 1
27 Nov 2022 – From PCR London Valves 2022
Discover a series of TAVI challenges shared by your peers: a transfemoral TAVR through a severely tortuous and horizontal aorta in a morbidly obese patient, TAVI for pure non-calcified severe aortic regurgitation in a large annulus, peripheral access calcifications and more.
Rapid-fire abstracts: session 1
27 Nov 2022 – From PCR London Valves 2022
Watch this PCR LV 2022 session to get clinical outcomes after TAVR in obese and non-obese patients with small aortic annuli, to find out how non-calcific aortic valve tissue quantified from coronary CT angiography can predict one-year mortality post-TAVI, and even more!
TMVR challenges
27 Nov 2022 – From PCR London Valves 2022
Challenges in this session of PCR LV 2022 include hybrid valve implantation for mitral annular calcification, transcatheter double-valve implantation complicated by mitral bioprosthesis migration, and transcatheter transseptal mitral valve implantation. Watch now to find out more!
Rapid-fire clinical cases: Session 1
27 Nov 2022 – From PCR London Valves 2022
Discover a selection of PCR London Valves 2022 case submissions in this session: quadricuspid aortic valve with pure regurgitation treated with Evolut PRO, complex high-risk patient with severe aortic regurgitation and extra-large anatomy, snare-assisted TAVI in case of calcified sinotubular junction, and more!
TRISCEND, ACURATE neo2, the LuX-Valve System: Top Late-Breaking Trials from PCR London Vaves 2022
27 Nov 2022 – From PCR London Valves 2022
Discover a selection of PCR London Valves 2022 Late-Breaking Trial submissions and learn more about the latest evidence evidence concerning new transcatheter valve devices, emerging innovative devices as well as highlighted content from the EuroIntervention journal.
Rapid-fire abstracts: session 2
27 Nov 2022 – From PCR London Valves 2022
Take advantage of this PCR LV 2022 session to discover more abstracts and learn more about how to predict TAVI bicuspid aortic valve re-access, or right ventricle-pulmonary artery coupling in patients with severe aortic stenosis, among others.
